View Older Stories View More Recent Stories

Oct 18, 2022 08:30AM VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
Oct 18, 2022 08:30AM VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
Oct 13, 2022 01:30PM Form SC 13G/A First Light Acquisition Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Oct 13, 2022 07:22AM VectivBio Holding AG (VECT) Prices $125 Million Underwritten Offering of Ordinary Shares at $7.50/sh
Oct 13, 2022 07:20AM VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares
Oct 13, 2022 07:20AM VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares
Oct 11, 2022 08:56AM Form SC 13G/A First Light Acquisition Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Sep 23, 2022 07:01AM Sonendo, Inc (SONX) Announces $63M Private Placement Priced at $0.95/sh
Sep 23, 2022 07:00AM Sonendo, Inc. Announces $63 Million Private Placement
Sep 19, 2022 08:00AM Ventyx Biosciences (VTYX) Announces $176.6 Million Private Placement of Common Stock
Sep 19, 2022 08:00AM Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock
Jul 11, 2022 06:25PM Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
Jul 11, 2022 06:25PM Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
Jul 11, 2022 10:28AM Form SC 13G/A Elevation Oncology, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jul 8, 2022 07:00AM Annexon (ANNX) Announces $130 Million Private Placement Financing
Jul 8, 2022 07:00AM Annexon Announces $130 Million Private Placement Financing
Jul 8, 2022 07:00AM Annexon Announces $130 Million Private Placement Financing
Jun 15, 2022 11:29AM Form SC 13G Real Good Food Company, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jun 13, 2022 01:50PM Form SC 13G MELI Kaszek Pioneer Corp Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jun 10, 2022 09:03AM Form SC 13G/A Elevation Oncology, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Apr 8, 2022 09:47AM Form SC 13G/A CHANNELADVISOR CORP Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 14, 2022 09:43AM Form SC 13G/A CYTOKINETICS INC Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 14, 2022 09:29AM Form SC 13G First Light Acquisition Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 14, 2022 09:25AM Form SC 13G DICE Therapeutics, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 14, 2022 09:19AM Form SC 13G Elevation Oncology, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 14, 2022 09:15AM Form SC 13G Xenon Pharmaceuticals Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 8, 2022 08:00AM Congruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding
Jan 21, 2022 05:22AM Precision Medicine Market Size Worth USD 126 Billion | 12.50% CAGR by 2025
Jan 10, 2022 11:10AM Form SC 13G Crinetics Pharmaceutical Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jan 10, 2022 07:30AM Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases
Oct 14, 2021 09:25AM First Trust Launches the First Trust Multi-Manager Small Cap Opportunities ETF
Oct 4, 2021 10:03AM Form SC 13G/A RumbleOn, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Aug 24, 2021 08:30AM DiCE Molecules Announces $60 Million Series C-1 Financing
Aug 23, 2021 04:55PM Form SC 13G/A ESSA Pharma Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jul 19, 2021 08:00AM Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline
Jul 19, 2021 08:00AM Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline
May 11, 2021 06:00AM Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
May 10, 2021 09:45AM Form SC 13G RumbleON, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
May 5, 2021 12:00AM NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
Apr 12, 2021 04:05PM Crinetics Pharmaceuticals Announces Closing of Common Stock Offering
Apr 12, 2021 04:05PM Crinetics Pharmaceuticals Announces Closing of Common Stock Offering
Mar 19, 2021 08:04AM X4 Pharmaceuticals (XFOR) Announces $55.0 Million At-the-Market Private Placement Financing of Common Stock, Warrants
Mar 19, 2021 08:01AM X4 Pharmaceuticals Announces $55.0 Million At-the-Market Private Placement Financing
Feb 24, 2021 08:00AM Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs
Feb 16, 2021 09:42AM Form SC 13G ESSA Pharma Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 16, 2021 09:41AM Form SC 13G CHANNELADVISOR CORP Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 16, 2021 09:23AM Form SC 13G CHANNELADVISOR CORP Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Feb 16, 2021 09:17AM Form SC 13G ESSA Pharma Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Jan 27, 2021 03:14PM BioMedNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs Agreements to Acquire Leading Digital Musculoskeletal Company, Raise $70 Million Through Private Placement
Jan 27, 2021 06:35AM DarioHealth (DRIO) Announces Acquisition of Leading Digital Musculoskeletal Company Upright Technologies and $70 Million Financing
View More Recent Stories View Older Stories